Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1517-1519

  Fernandez, Marisol ^a   Hickman, Melissa E ^a   Baker, Carol J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFALOTIN; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; MEROPENEM; PENICILLIN G; RIFAMPICIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; MENINGITIS; NEWBORN CARE; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

EID: 0031860571     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1517     Document Type: Article

References (26)

1. American Academy of Pediatrics, Committee on Infectious Diseases, and Committee on Fetus and Newborn. 1992. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 90:775-778.
2. American Academy of Pediatrics, Committee on Infectious Diseases, and Committee on Fetus and Newborn. 1997. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 99:489-496.
3. Baker, C. J., B. J. Webb, and F. F. Barrett. 1976. Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob. Agents Chemother. 10:128-133.
4. Baker, C. J., and F. F. Barrett. 1974. Group B streptococcal infections in infants: the importance of serotypes. JAMA 230:1158-1160.
5. Baker, C. J., and M. S. Edwards. 1995. Group B streptococcal infections, p. 980-1054. In J. S. Remington and J. O. Klein (ed.), Infectious diseases of the fetus and newborn infant, 4th ed. W. B. Saunders Co., Philadelphia, Pa.
6. Baker, C. N., C. Thornsberry, and R. R. Facklam. 1981. Synergism, killing, kinetics, and antimicrobial susceptibility of group A and B streptococci. Antimicrob. Agents Chemother. 19:716-725.
7. Bayer, A. S., J. O. Morrison, and K.-S. Kim. 1982. Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci. Antimicrob. Agents Chemother. 21:344-346.
8. Berkowitz, K., J. A. Regan, and E. Greenberg. 1990. Antibiotic resistance patterns of group B streptococci in pregnant women. J. Clin. Microbiol. 28:5-7.
9. Betriu, C., M. Gomez, A. Sanchez, A. Cruceyra, J. Romero, and J. J. Picazo. 1994. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob. Agents Chemother. 38:2183-2186.
10. Blumberg, H. M., D. S. Stephens, M. Modansky, M. Erwin, J. Elliot, R. R. Facklam, A. Schuchat, W. Baughman, and M. M. Farley. 1996. Invasive group B streptococcal disease: the emergence of serotype V. J. Infect. Dis. 173:365-373.
11. Centers for Disease Control and Prevention. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. Morbid. Mortal. Weekly Rep. 45:1-27.
12. Gardner, S. E., M. D. Vow, L. J. Leeds, P. K. Thompson, E. O. Mason, Jr., and D. J. Clark. 1979. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. Am. J. Obstet. Gynecol. 135:1062-1065.
13. Jacobs, M. R., F. Kelly, and W. T. Speck. 1982. Susceptibility of group B streptococci to 16 β-lactam antibiotics, including new penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 22:897-900.
14. Jelinkova, J., and J. Motlova. 1985. Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V. J. Clin. Microbiol. 21:361-362.
15. Jernigan, D. B., M. S. Centron, and R. F. Breiman. 1996. Minimizing the impact of drug-resistant Streptococcus pneumoniae: a strategy from the DRSP working group. JAMA 275:206-209.
16. Jones, W. F., Jr., H. A. Feldman, and M. Finland. 1957. Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro. Am. J. Clin. Pathol. 27:159-169.
17. Kim, K. S. 1985. Antimicrobial susceptibility of GBS. Antibiot. Chemother. 35:83-89.
18. Lancefield, R. C. 1934. Serologic differentiation of specific types of bovine hemolytic streptococci (group B). J. Exp. Med. 59:441-458.
19. Meyn, L. A., and S. L. Hillier. 1997. Ampicillin susceptibilities of vaginal and placental isolates of group B streptococcus and Escherichia coli obtained between 1992 and 1994. Antimicrob. Agents Chemother. 41:1173-1174.
20. Mulder, C., P. Bol, A. Nabbe, and B. Zanen. 1985. Susceptibility to six antibiotics of group B streptococci isolated from cerebrospinal fluid. Scand. J. Infect. Dis. 17:191-193.
21. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Persson, K. M.-S., and A. Forsgren. 1984. Antimicrobial susceptibility of Group B streptococci. Eur. J. Clin. Microbiol. 5:165-167.
23. Schuchat, A., and J. D. Wenger. 1994. Epidemiology of group B streptococcal disease: risk factors, prevention strategies, and vaccine development. Epidemiol. Rev. 16:374-102.
24. Severin, M. J., and J. L. Wiley. 1976. Change in susceptibility of group B streptococci to penicillin B from 1968 through 1975. Antimicrob. Agents Chemother. 10:380-381.
25. Siegel, J. D., G. H. McCracken, Jr., N. Threlkeld, B. Milvenan, and C. R. Rosenfeld. 1980. Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. N. Engl. J. Med. 303:769-775.
26. Wu, J.-J., K.-Y. Lin, P.-R. Hsueh, J.-W. Liu, H.-I. Pan, and S.-M. Sheu. 1997. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:844-846.